Trimethylamine-N-oxide: a potential biomarker and therapeutic target in ischemic stroke

被引：5

作者：

Liu, Yuan ^{[1
]}

Qu, Juan ^{[2
]}

Xu, Junjie ^{[2
]}

Gu, Aiming ^{[2
]}

Deng, Dezhi ^{[2
]}

Jia, Xiaodan ^{[2
]}

Wang, Baoxiang ^{[2
]}

机构：

[1] Zhejiang Chinese Med Univ, Jiaxing Univ Master Degree Cultivat Base, Jiaxing, Peoples R China

[2] Jiaxing Univ, Hosp Jiaxing 1, Dept Neurol, Affiliated Hosp, Jiaxing, Peoples R China

来源：

FRONTIERS IN NEUROLOGY | 2023年 / 14卷

关键词：

ischemic stroke; trimethylamine-N-oxide; gut microbiota; trimethylamine; stroke; GUT MICROBIOTA; L-CARNITINE; METABOLISM; SUPPLEMENTATION; ASSOCIATION; THROMBOSIS; INCREASES;

D O I：

10.3389/fneur.2023.1156879

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Ischemic stroke is by far the most common cerebrovascular disease and a major burden to the global economy and public health. Trimethylamine-N-oxide (TMAO), a small molecule compound produced by the metabolism of intestinal microorganisms, is reportedly associated with the risk of stroke, as well as the severity and prognosis of stroke; however, this conclusion remains contentious. This article reviews the production of TMAO, TMAO's relationship with different etiological types of ischemic stroke, and the possibility of reducing TMAO levels to improve the prognosis of ischemic stroke.

引用

页数：8

共 50 条

[1] Serum levels of Trimethylamine-N-oxide in patients with ischemic stroke
Rexidamu, Maimaiti
Li, Hongmei
Jin, Haiyan
Huang, Jiankang
BIOSCIENCE REPORTS, 2019, 39
[2] Trimethylamine-N-Oxide Pathway: A Potential Target for the Treatment of MAFLD
Li, Xun
Hong, Jia
Wang, Yao
Pei, Maohua
Wang, Luwen
Gong, Zuojiong
FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
[3] Gut Microbe-Generated Metabolite Trimethylamine-N-Oxide and Ischemic Stroke
Li, Zhen
He, Xinyi
Fang, Qi
Yin, Xulong
BIOMOLECULES, 2024, 14 (11)
[4] Transferrin predicts trimethylamine-N-oxide levels and is a potential biomarker of cardiovascular disease
Lamuel D. Bean
Jeffrey J. Wing
Randall E. Harris
Suzanne M. Smart
Subha V. Raman
M. Wesley Milks
BMC Cardiovascular Disorders, 22
[5] Transferrin predicts trimethylamine-N-oxide levels and is a potential biomarker of cardiovascular disease
Bean, Lamuel D.
Wing, Jeffrey J.
Harris, Randall E.
Smart, Suzanne M.
Raman, Subha V.
Milks, M. Wesley
BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
[6] Trimethylamine-N-oxide and cerebral stroke risk: A review
Dolkar, Phurbu
Deyang, Tenzin
Anand, Nikhilesh
Rathipriya, Annan Gopinath
Hediyal, Tousif Ahmed
Chandrasekaran, Vichitra
Krishnamoorthy, Naveen Kumar
Gorantla, Vasavi Rakesh
Bishir, Muhammed
Rashan, Luay
Chang, Sulie L.
Sakharkar, Meena Kishore
Yang, Jian
Chidambaram, Saravana Babu
NEUROBIOLOGY OF DISEASE, 2024, 192
[7] Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target
Janeiro, Manuel H.
Ramirez, Maria J.
Milagro, Fermin I.
Alfredo Martinez, J.
Solas, Maite
NUTRIENTS, 2018, 10 (10)
[8] Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome
Barrea, Luigi
Annunziata, Giuseppe
Muscogiuri, Giovanna
Di Somma, Carolina
Laudisio, Daniela
Maisto, Maria
de Alteriis, Giulia
Tenore, Gian Carlo
Colao, Annamaria
Savastano, Silvia
NUTRIENTS, 2018, 10 (12)
[9] The Metabolite Trimethylamine-N-Oxide is an Emergent Biomarker of Human Health
Chhibber-Goel, Jyoti
Singhal, Varsha
Parakh, Neeraj
Bhargava, Balram
Sharma, Amit
CURRENT MEDICINAL CHEMISTRY, 2017, 24 (36) : 3942 - 3953
[10] The roles of trimethylamine-N-oxide in atherosclerosis and its potential therapeutic aspect: A literature review
Oktaviono, Yudi Her
Lamara, Ariikah Dyah
Saputra, Pandit Bagus Tri
Arnindita, Jannatin Nisa
Pasahari, Diar
Saputra, Mahendra Eko
Suasti, Ni Made Adnya
BIOMOLECULES AND BIOMEDICINE, 2023, 23 (06): : 936 - 948

← 1 2 3 4 5 →